UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-02 | Future report Set alerts | |
| Q2 2022 | 2022-07-28 | 1.50 | 1.50 |
| Q1 2022 | 2022-04-28 | 1.36 | 1.36 |
| Q4 2021 | 2022-02-03 | 1.25 | 1.25 |
| Q3 2021 | 2021-11-04 | 1.30 | 1.30 |
| Q2 2021 | 2021-07-29 | 1.29 | 1.29 |
| Q1 2021 | 2021-05-06 | 1.17 | 1.17 |
| Q4 2020 | 2021-02-04 | 1.08 | 1.08 |
| Q3 2020 | 2020-10-29 | 0.00 | 0.00 |
| Q2 2020 | 2020-07-30 | 0.85 | 0.42 |
| 2016-05-26 | Downgrade | Wedbush | Outperform to Neutral | $62.00 |
| 2016-05-12 | Downgrade | Wedbush | Outperform to Neutral | $62.00 |
| 2016-02-08 | Lower Price Target | Wedbush | Outperform | $66.00 to $62.00 |
| 2016-01-04 | Reiterated Rating | Wedbush | Buy | |
| 2015-12-29 | Reiterated Rating | Wedbush | Outperform | $70.00 to $66.00 |
| 2015-12-03 | Lower Price Target | JPMorgan Chase & Co. | Outperform | $70.00 to $68.00 |
| 2015-10-13 | Upgrade | KeyBanc | Sector Weight to Overweight | $70.00 |
| 2015-10-13 | Upgrade | KeyCorp | Sector Weight to Overweight | $70.00 |
| 2015-08-31 | Reiterated Rating | Wedbush | Outperform | $70.00 |
| 2015-08-10 | Lower Price Target | Wedbush | Outperform | $75.00 to $70.00 |
| 2015-07-02 | Reiterated Rating | Wedbush | Buy | $75.00 |
| 2015-02-02 | Lower Price Target | JPMorgan Chase & Co. | Overweight | $79.00 to $75.00 |
| 2015-01-29 | Lower Price Target | Wedbush | Outperform | $80.00 to $75.00 |
| 2014-10-31 | Downgrade | First Analysis | Overweight to Equal Weight | $74.00 |
| 2014-09-19 | Upgrade | Sidoti | Neutral to Buy | |
| 2014-07-21 | Initiated Coverage | Wedbush | Outperform | |
| 2014-03-20 | Upgrade | First Analysis | Equal Weight to Overweight | $74.00 |
| 2014-03-10 | Upgrade | Ned Davis Research | Neutral to Buy | |
| 2014-02-24 | Upgrade | Ned Davis Research | Neutral to Buy | |
| 2013-10-21 | Downgrade | Deutsche Bank | Buy to Hold | |
| 2013-10-21 | Boost Price Target | Berenberg Bank | Hold | €69.00 to €84.40 |
| 2007-01-25 | Downgrade | First Analysis Sec | Overweight to Equal-Weight |
| 2016-05-26 | Downgrade | Wedbush | Outperform to Neutral | $62.00 |
| 2016-05-12 | Downgrade | Wedbush | Outperform to Neutral | $62.00 |
| 2016-02-08 | Lower Price Target | Wedbush | Outperform | $66.00 to $62.00 |
| 2016-01-04 | Reiterated Rating | Wedbush | Buy | |
| 2015-12-29 | Reiterated Rating | Wedbush | Outperform | $70.00 to $66.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In MTX 193 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Inc. | 5.19M |
| Vanguard Group, Inc | 3.59M |
| DIMENSIONAL FUND ADVISORS LP | 2.16M |
| BlackRock Fund Advisors | 2.09M |
| MACQUARIE GROUP LTD | 1.84M |
| FRANKLIN RESOURCES INC | 1.22M |
| STATE STREET CORP | 1.18M |
| AMERICAN CENTURY COMPANIES INC | 1.18M |
| VICTORY CAPITAL MANAGEMENT INC | 1.06M |
| BlackRock Institutional Trust Company, N.A. | 1.04M |
| EATON VANCE MANAGEMENT | 1.01M |
| ROYCE & ASSOCIATES LLC | 0.69M |
| GEODE CAPITAL MANAGEMENT, LLC | 0.65M |
| NORTHERN TRUST CORP | 0.62M |
| GANNETT WELSH & KOTLER | 0.62M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| MUSCARI JOSEPH C Executive Chairman | 0.96% (332050) | DAN / ENS / MTX / |
| DIETRICH DOUGLAS T Chief Financial Officer | 0.17% (59504) | MTX / |
| Meek Thomas J Senior Vice President | 0.15% (50708) | MTX / |
| MONAGLE DJ III SENIOR VICE PRESIDENT | 0.11% (39057) | MTX / |
| MAYGER DOUGLAS W VICE PRESIDENT | 0.10% (34415) | MTX / |
| Hastings Jonathan J Vice President | 0.08% (28072) | MTX / |
| CASTAGNA GARY L Senior Vice President | 0.08% (27838) | ACO / MTX / |
| CIPOLLA MICHAEL VICE PRESIDENT | 0.07% (24869) | MTX / |
| Schut Johannes C Vice President | 0.04% (15045) | MTX / |
| ARGIRAKIS BRETT Vice President | 0.02% (5945) | MTX / |
| HONEY RICK VICE PRESIDENT | 0.01% (4711) | MTX / |
| JONES ANDREW M Vice President | 0.01% (3634) | MTX / |
| Carpenter Patrick Vice President | 0.01% (1740) | ACO / MTX / |
UM